Key Takeaways
- • Alternative investments have entered mainstream portfolios over the past two decades, expanding beyond institutional investors to individual retail investors, yet the net benefits have been "modest at best and negative at worst" despite aggressive marketing claims.
- • Two primary sales arguments drive adoption of alternatives: low correlation with stocks and bonds enabling diversification benefits, and the potential to generate alpha or excess returns—both premises face scrutiny in actual performance delivery.
- • Marketing and flawed metrics obscure underperformance, with alternative investment strategies often relying on exaggerated diversification arguments and misleading performance presentations rather than substantive risk-adjusted returns.
- • Institutional investors have been underwhelmed by alternative investment outcomes, raising fundamental questions about whether the promised risk-return tradeoff materially improves portfolio construction versus traditional stock-bond allocations.
- • Regulatory and disclosure guardrails for individual investors warrant strengthening, as retail participation in alternative assets (venture capital, private equity, hedge funds, crypto, real estate, collectibles) has expanded without corresponding investor protections or realistic expectations-setting.
Summary
Aswath Damodaran's analysis challenges the fundamental value proposition that has driven alternative investments into mainstream portfolios over the past two decades. While alternative asset classes—including venture capital, private equity, hedge funds, real estate, cryptocurrencies, and collectibles—have long existed in financial markets, they remained inaccessible to most investors until recent years. The democratization of these strategies, initially through institutional channels and subsequently through retail offerings, has been predicated on a compelling but increasingly questioned narrative: that blending alternatives with traditional stock-and-bond portfolios creates superior risk-return tradeoffs.
The sales case for alternatives rests on two economic arguments. First, proponents contend that alternative assets exhibit low correlation with equities and fixed income, thereby providing genuine diversification benefits that reduce portfolio volatility without sacrificing returns. Second, they promise alpha generation—excess returns beyond what market-risk factors explain—particularly through private investments and derivative-based strategies. Despite this compelling framing, Damodaran's assessment suggests the delivered outcomes have disappointed, particularly for institutional investors who entered alternatives with substantial capital commitments.
The gap between promise and performance appears driven by several factors, including reliance on marketing spin rather than rigorous performance analysis, application of flawed or misleading metrics that exaggerate returns and understate risks, and overselling of the diversification argument. The correlation benefits often touted by alternatives managers have not materialized as advertised, and the alpha generation—once the cornerstone of alternatives' value proposition—has proven elusive across many strategies.
As individual investors gain access to alternative investments with less institutional sophistication, the stakes for policy and disclosure standards increase. Damodaran raises questions about whether current guardrails adequately protect retail participants from unrealistic expectations and inflated performance claims. Without more stringent oversight and realistic framing, individual investors may bear disproportionate costs from the gap between alternative investments' promised benefits and their actual returns.
The sales case for alternatives rests on two economic arguments. First, proponents contend that alternative assets exhibit low correlation with equities and fixed income, thereby providing genuine diversification benefits that reduce portfolio volatility without sacrificing returns. Second, they promise alpha generation—excess returns beyond what market-risk factors explain—particularly through private investments and derivative-based strategies. Despite this compelling framing, Damodaran's assessment suggests the delivered outcomes have disappointed, particularly for institutional investors who entered alternatives with substantial capital commitments.
The gap between promise and performance appears driven by several factors, including reliance on marketing spin rather than rigorous performance analysis, application of flawed or misleading metrics that exaggerate returns and understate risks, and overselling of the diversification argument. The correlation benefits often touted by alternatives managers have not materialized as advertised, and the alpha generation—once the cornerstone of alternatives' value proposition—has proven elusive across many strategies.
As individual investors gain access to alternative investments with less institutional sophistication, the stakes for policy and disclosure standards increase. Damodaran raises questions about whether current guardrails adequately protect retail participants from unrealistic expectations and inflated performance claims. Without more stringent oversight and realistic framing, individual investors may bear disproportionate costs from the gap between alternative investments' promised benefits and their actual returns.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.